STAT2: A Potential Drug Target and Biomarker (G6773)

Target Name: STAT2

NCBI ID: G6773

STAT2

STAT2: A Potential Drug Target and Biomarker

STAT2 (Signal Transducer and Activator of Transcription 2) is a protein that plays a critical role in cell signaling pathways. It is a transcription factor that regulates the expression of genes in response to various signaling cues. The study of STAT2 and its potential as a drug target has generated a lot of interest in recent years.

STAT2 is a key transcription factor that is involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. It is a protein that can interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. These transcription factors are involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

One of the key functions of STAT2 is its role in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged cells in the body. However, when cells are exposed to various signaling cues, they can undergo apoptosis . STAT2 is involved in the regulation of apoptosis by regulating the expression of genes that are involved in the process.

Another function of STAT2 is its role in the regulation of cell signaling pathways. Signal transduction is the process by which cells respond to various signaling cues, including hormones and other signaling molecules. Signal transduction involves the interaction of various signaling molecules with their respective receptors. STAT2 is involved in the regulation of signal transduction pathways by regulating the expression of genes that are involved in the process.

STAT2 is also involved in the regulation of cellular differentiation. Differentiation is the process by which cells develop into specific types of cells. STAT2 is involved in the regulation of cellular differentiation by regulating the expression of genes that are involved in the process.

In addition to its role in cell signaling pathways, STAT2 is also involved in the regulation of inflammation. Inflammation is a natural response of the body's immune system to various harmful stimuli, including bacteria, viruses, and other foreign particles. However, when inflammation becomes chronic, it can lead to a variety of diseases, including heart disease, cancer, and rheumatoid arthritis.

STAT2 is involved in the regulation of inflammation by regulating the expression of genes that are involved in the process.

As a result of its involvement in various cellular processes, STAT2 has generated a lot of interest as a potential drug target. Researchers are studying the various functions of STAT2 and its potential as a drug.

One of the main advantages of STAT2 as a drug target is its involvement in the regulation of cellular signaling pathways. Drugs that target STAT2 have the potential to regulate various cellular processes and have a wide range of potential therapeutic applications. For example, drugs that target STAT2 has been shown to have anti-inflammatory effects, anti-cancer effects, and neuroprotective effects.

Another advantage of STAT2 as a drug target is its involvement in the regulation of cell apoptosis. Drugs that target STAT2 have been shown to have pro-apoptotic effects, which can be useful in the treatment of certain types of cancer.

In addition to its potential therapeutic applications, STAT2 is also an attractive biomarker for the diagnosis and monitoring of various diseases. The levels of STAT2 have been shown to be involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. Therefore, changes in the levels of STAT2 can be used as a diagnostic or predictive factor for various diseases.

In conclusion, STAT2 is a protein that plays a critical role in cell signaling pathways and has the potential as a drug target. Its involvement in the regulation of cellular processes makes it an attractive target for the development of new therapeutic drugs with a wide range of potential therapeutic applications.

Protein Name: Signal Transducer And Activator Of Transcription 2

Functions: Signal transducer and activator of transcription that mediates signaling by type I interferons (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state (PubMed:9020188, PubMed:23391734). In addition, has also a negative feedback regulatory role in the type I interferon signaling by recruiting USP18 to the type I IFN receptor subunit IFNAR2 thereby mitigating the response to type I IFNs (PubMed:28165510). Acts as a regulator of mitochondrial fission by modulating the phosphorylation of DNM1L at 'Ser-616' and 'Ser-637' which activate and inactivate the GTPase activity of DNM1L respectively (PubMed:26122121, PubMed:23391734, PubMed:9020188)

The "STAT2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STAT2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets